# An Examination of the Blood Pressure Lowering Ability and Safety of Olmesartan Medoxomil in Patients With Type II Diabetes

> **NCT00403481** · PHASE4 · COMPLETED · sponsor: **Daiichi Sankyo** · enrollment: 192 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** olmesartan medoxomil
- **DRUG:** Olmesartan medoxomil plus Hydrochlorothiazide

## Key facts

- **NCT ID:** NCT00403481
- **Lead sponsor:** Daiichi Sankyo
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-11
- **Primary completion:** 2007-11
- **Final completion:** 2007-12
- **Target enrollment:** 192 (ACTUAL)
- **Last updated:** 2016-11-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00403481

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00403481, "An Examination of the Blood Pressure Lowering Ability and Safety of Olmesartan Medoxomil in Patients With Type II Diabetes". Retrieved via MORVS 2026-10-22 from https://api.morvs.ai/clinical/NCT00403481. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*